View all research projects
Research project

Against Breast Cancer programme grant in Therapeutic Antibodies

Staff

Lead researcher

Dr Charlie Birts

Lecturer in Antibody Therapeutics

Research interests

  • Antibody Therapy
  • Metastic Breast Cancer
  • Obesity and Breast Cancer
Connect with Charlie

Email: [email protected]

Research outputs

Could anionic LDL be a ligand for RAGE and TREM2 in addition to LOX-1 and thus exacerbate lung disease and dementia?
Charles N. Birts & David C. Wilton, 2023, Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 1869(8)
DOI: 10.1016/j.bbadis.2023.166837
Type: article
The role of three-dimensional in vitro models in modelling the inflammatory microenvironment associated with obesity in breast cancer
Rhianna Rachael Romany Blyth, Charlie N. Birts & Stephen A. Beers, 2023, Breast Cancer Research, 25(1)
DOI: 10.1186/s13058-023-01700-w
Type: review
Prognostic significance of crown-like structures to trastuzumab response in patients with primary invasive HER2 + breast carcinoma
Charles N. Birts, Constantinos Savva, Stéphanie A. Laversin, Alicia Lefas, Jamie Krishnan, Aron Schapira, Margaret Ashton-Key, Max Crispin, Peter W.M. Johnson, Jeremy P. Blaydes, Ellen Copson, Ramsey I. Cutress & Stephen A. Beers, 2022, Scientific Reports, 12(1)
DOI: 10.1038/s41598-022-11696-6
Type: article
Age, obesity and hyperglycaemia
Charles N. Birts & David C. Wilton, 2021, Medical Hypotheses, 155
DOI: 10.1016/j.mehy.2021.110646
Type: article